Starling Oncology STLN
NASDAQ STLN
$6.35 +0.13 (+2.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Starling Oncology (STLN) Price to Earnings (2021 - 2022)

Updated

Starling Oncology's Price to Earnings was 795.32 in Q4 2022, up 232.1% from the prior quarter.

Analysis

Starling Oncology (STLN) Price to Earnings (2021 - 2022) Analysis & Trends

From Q1 2021 onward, Starling Oncology has reported Price to Earnings for 5 quarters.

  • Per Business Quant data, STLN's Price to Earnings in the three quarters before Q4 2022 was 239.51 (Q3 2022), 100.05 (Q2 2022) and 175.75 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn
6 Tenet Healthcare 20.83 Bn 11.98 Bn -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn
9 Encompass Health 11.82 Bn 12.29 Bn -
10 Starling Oncology 637.98 Mn 505.38 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 795.32
Sep 30, 2022 239.51
Jun 30, 2022 100.05
Mar 31, 2022 175.75
Mar 31, 2021 344.69
API Access

Starling Oncology Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=STLN&period=max&api_key=YOUR_API_KEY